Molecular basis of CXC chemokine receptor 3 ligand multispecificity
Science Advances · 17.04.2026 · 12 (16)
DOI: 10.1126/sciadv.adz3767 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 17.04.2026. Verfasst von Alexandre Bouyssou und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical and Cellular Pharmacology, Genentech Inc., South San Francisco, CA 94080, USA. Hauptthemen laut MEDLINE: Receptors, CXCR3. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
C-X-C motif chemokine receptor 3 (CXCR3) is essential for immune cell functions and pivotal in T helper 1 cell infiltration in autoimmune and chronic inflammatory diseases and in tumor proliferation and metastasis, but the mechanisms by which the endogenous ligands CXCL9, CXCL10, and CXCL11 differentially recognize and activate CXCR3 are not fully understood. Here, we present cryo–electron microscopy structures of all three chemokine-CXCR3-G i complexes, complemented by cell binding studies and functional mutagenesis data. We systematically compare the pharmacological and interaction profiles of CXCL9, CXCL10, and CXCL11 to rationalize their varying efficacies and potencies and to reveal the critical role of the membrane-distal CXCR3 N terminus in ligand binding and signaling. Using chimeric chemokines and molecular dynamics, we reveal the signaling plasticity of chemokine ligands and signaling determinants. Together, these insights enable us to propose a multimodal binding and activation framework that explains CXCR3 chemokine ligand multispecificity and signaling versatility and offer tools to interrogate and modulate CXCR3 biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemical and Cellular Pharmacology, Genentech Inc., South San Francisco, CA 94080, USA.
- Department of Structural Biology, Genentech Inc., South San Francisco, CA 94080, USA.
- Department of Proteomic & Genomic Technologies, Genentech Inc., South San Francisco, CA 94080, USA.
- Department of Biomolecular Research, Genentech Inc., South San Francisco, CA 94080, USA.
- Department of Computational Chemistry, Genentech Inc., South San Francisco, CA 94080, USA.
ORCID-Profile: Alexandre Bouyssou, Dawei Sun, Tricia Zhou, Shannon Smith, Hoangdung Ho, Matthew Johnson, Caleigh Azumaya, Sigrid Noreng, Ying Yang, Eric Janezic, Laëtitia Comps-Agrar, Matthieu Masureel
Zitieren
APA
Bouyssou, A., Sun, D., Zhou, T., Smith, S., Ho, H., Johnson, M., Azumaya, C., Noreng, S., Liu, P., Ti, S., Joshi, P., Tam, C., Yang, Y., Janezic, E., Comps-Agrar, L., & Masureel, M. (2026). Molecular basis of CXC chemokine receptor 3 ligand multispecificity. Science Advances, 12(16). https://doi.org/10.1126/sciadv.adz3767
Vancouver
Bouyssou A, Sun D, Zhou T, Smith S, Ho H, Johnson M, et al. Molecular basis of CXC chemokine receptor 3 ligand multispecificity. Science Advances. 2026;12(16). doi:10.1126/sciadv.adz3767
BibTeX
@article{Bouyssou2026,
author = {Bouyssou, Alexandre and Sun, Dawei and Zhou, Tricia and Smith, Shannon and Ho, Hoangdung and Johnson, Matthew and Azumaya, Caleigh and Noreng, Sigrid and Liu, Peter and Ti, Shu and Joshi, Prajakta and Tam, Christine and Yang, Ying and Janezic, Eric and Comps-Agrar, Laëtitia and Masureel, Matthieu},
title = {Molecular basis of CXC chemokine receptor 3 ligand multispecificity},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {16},
doi = {10.1126/sciadv.adz3767}
}
EUVIMED